IL82083A0 - Carcinostatic agents containing a certain isoindoloquinazoline and their preparation - Google Patents
Carcinostatic agents containing a certain isoindoloquinazoline and their preparationInfo
- Publication number
- IL82083A0 IL82083A0 IL82083A IL8208387A IL82083A0 IL 82083 A0 IL82083 A0 IL 82083A0 IL 82083 A IL82083 A IL 82083A IL 8208387 A IL8208387 A IL 8208387A IL 82083 A0 IL82083 A0 IL 82083A0
- Authority
- IL
- Israel
- Prior art keywords
- isoindoloquinazoline
- preparation
- certain
- agents containing
- carcinostatic agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19863611194 DE3611194A1 (de) | 1986-04-04 | 1986-04-04 | Cancerostatisches mittel |
Publications (1)
Publication Number | Publication Date |
---|---|
IL82083A0 true IL82083A0 (en) | 1987-10-30 |
Family
ID=6297848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL82083A IL82083A0 (en) | 1986-04-04 | 1987-04-01 | Carcinostatic agents containing a certain isoindoloquinazoline and their preparation |
Country Status (8)
Country | Link |
---|---|
US (1) | US4757072A (xx) |
EP (1) | EP0240829B1 (xx) |
JP (1) | JPS62240619A (xx) |
AT (1) | ATE69951T1 (xx) |
CA (1) | CA1302270C (xx) |
DE (2) | DE3611194A1 (xx) |
IL (1) | IL82083A0 (xx) |
ZA (1) | ZA872430B (xx) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4980343A (en) * | 1988-10-27 | 1990-12-25 | Bayer Aktiengesellschaft | Aminooxodihydroisoindoloquinazoline carcinostatic agents |
EP0757559A4 (en) * | 1994-04-29 | 1999-06-23 | Molecular Medicine Center | COMPOSITION FOR THE ADMINISTRATION OF TOXIC RADIOISOTOPES IN THE CELL CORE AND THEIR USE |
US5804396A (en) * | 1994-10-12 | 1998-09-08 | Sugen, Inc. | Assay for agents active in proliferative disorders |
US5837524A (en) * | 1994-12-15 | 1998-11-17 | Sugen, Inc. | PYK2 related polynucleotide products |
US5837815A (en) * | 1994-12-15 | 1998-11-17 | Sugen, Inc. | PYK2 related polypeptide products |
DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
EP0832073B1 (en) * | 1995-06-07 | 2002-01-16 | Sugen, Inc. | Quinazolines and pharmaceutical compositions |
US7119174B2 (en) * | 1995-12-18 | 2006-10-10 | Sugen, Inc. | Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
US6716575B2 (en) | 1995-12-18 | 2004-04-06 | Sugen, Inc. | Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
PT948604E (pt) * | 1996-12-11 | 2004-10-29 | Univ New York Medical Ct | Produtos e metodos relacionados com pyk2 |
US6818440B2 (en) * | 1997-04-28 | 2004-11-16 | Sugen, Inc. | Diagnosis and treatment of alk-7 related disorders |
US6228641B1 (en) | 1997-05-20 | 2001-05-08 | Sugen, Inc. | Diagnosis and treatment of PTP04 related disorders |
US7115710B2 (en) * | 1997-06-11 | 2006-10-03 | Sugen, Inc. | Diagnosis and treatment of PTP related disorders |
US6342593B1 (en) | 1997-06-11 | 2002-01-29 | Sugen, Inc. | Diagnosis and treatment of ALP related disorders |
US6388063B1 (en) * | 1997-06-18 | 2002-05-14 | Sugen, Inc. | Diagnosis and treatment of SAD related disorders |
WO1999037787A2 (en) | 1998-01-21 | 1999-07-29 | Sugen, Inc. | Human orthologues of wart |
EP1073723B1 (en) * | 1998-04-14 | 2005-08-17 | Sugen, Inc. | Ste20-related protein kinases |
US6861442B1 (en) | 1998-12-30 | 2005-03-01 | Sugen, Inc. | PYK2 and inflammation |
US20030162223A1 (en) * | 1999-10-22 | 2003-08-28 | Lowery David E. | Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
US7364866B2 (en) * | 1999-10-22 | 2008-04-29 | Pharmacia & Upjohn Company | Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
EP1222273A2 (en) * | 1999-10-22 | 2002-07-17 | PHARMACIA & UPJOHN COMPANY | Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
US20030082534A1 (en) * | 1999-11-16 | 2003-05-01 | Peter Lind | Novel G protein-coupled receptors |
EP1237909A2 (en) * | 1999-11-16 | 2002-09-11 | PHARMACIA & UPJOHN COMPANY | Human g protein-coupled receptors |
US20030003451A1 (en) * | 2000-02-23 | 2003-01-02 | Gabriel Vogeli | Novel G protein-coupled receptors |
US7220824B1 (en) | 2000-08-28 | 2007-05-22 | Bayer Aktiengesellschaft | Integrin-mediated drug targeting |
EP1219634A1 (en) * | 2000-12-27 | 2002-07-03 | Bayer Aktiengesellschaft | Cytostatic-glycoconjugates having specifically cleavable peptidic linking units |
US20050069976A1 (en) * | 2001-02-14 | 2005-03-31 | Peter Lind | Protein-coupled receptor |
EP1238678A1 (en) * | 2001-03-08 | 2002-09-11 | Bayer Aktiengesellschaft | Enzyme-activated cytostatic conjugates with integrin ligands |
MX336675B (es) * | 2006-02-28 | 2016-01-27 | Centre Nat Rech Scient | Cribado para compuestos anticancerigenos utilizando actividad de netrina-1. |
JP2010511382A (ja) * | 2006-12-01 | 2010-04-15 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | 癌関連タンパク質キナーゼ |
-
1986
- 1986-04-04 DE DE19863611194 patent/DE3611194A1/de not_active Withdrawn
-
1987
- 1987-03-17 US US07/026,800 patent/US4757072A/en not_active Expired - Fee Related
- 1987-03-24 AT AT87104277T patent/ATE69951T1/de not_active IP Right Cessation
- 1987-03-24 EP EP87104277A patent/EP0240829B1/de not_active Expired - Lifetime
- 1987-03-24 DE DE8787104277T patent/DE3774918D1/de not_active Expired - Lifetime
- 1987-03-31 JP JP62079563A patent/JPS62240619A/ja active Pending
- 1987-04-01 IL IL82083A patent/IL82083A0/xx not_active IP Right Cessation
- 1987-04-02 CA CA000533703A patent/CA1302270C/en not_active Expired - Lifetime
- 1987-04-03 ZA ZA872430A patent/ZA872430B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0240829A3 (en) | 1990-05-23 |
ATE69951T1 (de) | 1991-12-15 |
CA1302270C (en) | 1992-06-02 |
US4757072A (en) | 1988-07-12 |
DE3611194A1 (de) | 1987-10-08 |
DE3774918D1 (de) | 1992-01-16 |
JPS62240619A (ja) | 1987-10-21 |
EP0240829B1 (de) | 1991-12-04 |
EP0240829A2 (de) | 1987-10-14 |
ZA872430B (en) | 1987-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL82083A0 (en) | Carcinostatic agents containing a certain isoindoloquinazoline and their preparation | |
DE3572653D1 (en) | Diaryl acetylenes, their preparation and use | |
ZA857270B (en) | Tetralin derivatives,their preparation and their use | |
EP0433581A3 (en) | Trocar's sleeve | |
GR1002750B (el) | Παραγωγα ισοκινολινης, παρασκευη τους και χρηση τους. | |
FR2611142B1 (fr) | Poche d'ostomie | |
ES8106291A1 (es) | Procedimiento para preparar derivados de 3-aminoproxiarilo | |
ZA904991B (en) | 5,11-dihydro-6h-dipyrido(3,2-b:2',3'-e)(1,4)-diazepin-6-ones and-thiones and their use for the treatment of aids | |
ES8700246A1 (es) | Procedimiento para la fabricacion de nuevos derivados de la cumarina | |
PL313078A1 (en) | Novel bis-naphtalimides for use in treating carcinoma | |
ZA879280B (en) | Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds | |
EP0307814A3 (en) | Tetracyclic quinazoline derivatives, preparation and use | |
AU4482985A (en) | Pyrro-1-yl-phenyl-dihydropyridazones | |
EP0331092A3 (en) | Alpha-amino-carboxylic-acid derivatives, their preparation and use | |
ZA874385B (en) | Hydroxypyrazole derivatives,their preparation and their use against microorganism | |
AP9801275A0 (en) | Use of tricyclic 1,4-dihydro-1,4-dioxo-1H-naphthalene derivatives resulting novel compounds and therapeutical use thereof | |
ZA796789B (en) | Novel 3,4-diaza-bicyclo (4.1.0) hept-2-en-5-ones, their preparation, and therapeutic agents containing these compounds | |
EP0365956A3 (en) | Carcinostatic agents | |
DE3666433D1 (en) | 4-substituted 10-cyanomethylene-thienoû4,3-e¨-benzo-azepines | |
EP0418990A3 (en) | 13-bromo and 13,14-dibromo ergoline, their preparation and their use | |
ZA916314B (en) | Use of mixed micelles | |
ZA88639B (en) | Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned | |
ZA822193B (en) | 5,6-dihydro-11-alkylene-morphanthridin-6-ones,their preparation,and drugs containing these compounds | |
DE3362130D1 (en) | 7-phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepines, their preparation and use | |
DE3561882D1 (en) | 10,11-dihydro-5h-dibenzoûa,d¨cycloheptadiene derivatives, their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |